electroCore, Inc. (NASDAQ:ECOR) Sees Large Decrease in Short Interest

electroCore, Inc. (NASDAQ:ECOR) was the target of a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 89,500 shares, a decrease of 22.8% from the December 15th total of 115,900 shares. Based on an average daily volume of 124,900 shares, the short-interest ratio is presently 0.7 days. Approximately 1.7% of the company’s shares are short sold.

Wall Street Analyst Weigh In

Separately, HC Wainwright lifted their price objective on electroCore from $22.00 to $25.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. International Assets Investment Management LLC boosted its holdings in electroCore by 689.1% in the third quarter. International Assets Investment Management LLC now owns 535,146 shares of the company’s stock worth $3,864,000 after acquiring an additional 467,326 shares in the last quarter. Renaissance Technologies LLC raised its position in shares of electroCore by 3.4% in the 2nd quarter. Renaissance Technologies LLC now owns 68,786 shares of the company’s stock worth $442,000 after purchasing an additional 2,270 shares during the last quarter. Geode Capital Management LLC raised its position in shares of electroCore by 10.3% in the 3rd quarter. Geode Capital Management LLC now owns 63,485 shares of the company’s stock worth $458,000 after purchasing an additional 5,951 shares during the last quarter. Finally, HighTower Advisors LLC bought a new position in electroCore in the 3rd quarter worth about $255,000. Institutional investors own 26.74% of the company’s stock.

electroCore Trading Up 0.6 %

Shares of NASDAQ ECOR opened at $15.70 on Thursday. The firm has a fifty day simple moving average of $13.87 and a two-hundred day simple moving average of $9.44. electroCore has a 12 month low of $5.32 and a 12 month high of $18.67. The firm has a market capitalization of $102.91 million, a PE ratio of -8.58 and a beta of 0.50.

electroCore Company Profile

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.